These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3118291)

  • 1. Computerized nuclear morphometry: a reproducible cytopathologic marker of head and neck cancer.
    Davis RK; Fox C; Heffner DK
    Otolaryngol Head Neck Surg; 1987 Jan; 96(1):15-21. PubMed ID: 3118291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of impulse cytophotometry in malignant tumors of the head and neck. A prognostic parameter?].
    Brauneis JW; Laskawi R; Schröder M; Göhde W
    HNO; 1989 Sep; 37(9):369-72. PubMed ID: 2808011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric analysis, ploidy and response to chemotherapy in squamous carcinomas of the head and neck.
    Helliwell TR; Atkinson MW; Cooke TG; Cooke LD; Stell PM
    Pathol Res Pract; 1989 Nov; 185(5):755-9. PubMed ID: 2483267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliation in incurable head and neck cancers: chemotherapy?
    Pantvaidya GH; D'Cruz AK; Prabhash K
    J Clin Oncol; 2005 Nov; 23(31):8128-9; author reply 8129-30. PubMed ID: 16258117
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
    Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
    Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.
    Jacobs C; Makuch R
    J Clin Oncol; 1990 May; 8(5):838-47. PubMed ID: 2185340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy.
    Baghi M; Mack MG; Hambek M; Bisdas S; Muerthel R; Wagenblast J; Gstoettner W; Vogl T; Knecht R
    Head Neck; 2007 Feb; 29(2):104-8. PubMed ID: 17111434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy prior to surgery in head and neck cancer.
    Paterson C; Robertson AG; Grose D; Correa PD; Rizwanullah M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):79-80. PubMed ID: 22070911
    [No Abstract]   [Full Text] [Related]  

  • 9. Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects?
    Ang KK
    J Clin Oncol; 2004 Dec; 22(23):4657-9. PubMed ID: 15534361
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized trial of adjuvant chemotherapy in head and neck cancer.
    Taylor SG; Applebaum E; Showel JL; Norusis M; Holinger LD; Hutchinson JC; Murthy AK; Caldarelli DD
    J Clin Oncol; 1985 May; 3(5):672-9. PubMed ID: 3889230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary evaluation of the effectiveness of induction chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck].
    Migdał K; Korzeniowski S; Skołyszewski J
    Otolaryngol Pol; 1991; 45(2):85-9. PubMed ID: 2067863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line chemotherapy in head and neck cancer: what should we expect?
    Büntzel J; Micke O
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):269-73. PubMed ID: 19275504
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
    Forastiere AA
    J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
    [No Abstract]   [Full Text] [Related]  

  • 15. Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
    Colevas AD
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):86-9. PubMed ID: 9348576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical remarks on chemotherapy of malignant tumors of the head and neck].
    Ganzer U; Bier H; Bachert C
    Laryngol Rhinol Otol (Stuttg); 1987 Apr; 66(4):200-4. PubMed ID: 2439860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
    Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck.
    Ensley JF; Maciorowski Z
    Semin Oncol; 1994 Jun; 21(3):330-9. PubMed ID: 8209264
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical outcome of induction chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Won HS; Lee YS; Jeon EK; Hong SH; Kang JH; Kim YS; Yoo le R; Sun DI; Kim MS
    Anticancer Res; 2014 Oct; 34(10):5709-14. PubMed ID: 25275078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.